Treatment of Ewing's sarcoma in the cooperative Ewing's sarcoma study group

Journal of Orthopaedic Science

Volumn 2, Issue 3, 1997, Pages 180-184

  Ozaki, Toshifumi ^a,b   Winkelmann, Winfried ^a   Willich, Normann ^a   Jürgens, Herbert ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Chemotherapy; Ewing's sarcoma; Prognosis; Radio therapy; Surgery

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; EWING SARCOMA; HUMAN; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0030917423     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02492975     Document Type: Review

References (41)

1. Bacci G, Toni A, Avella M, et al. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 1989;63:1477-86.
2. Barkley Jr HT, Martin RG, Romsdahl MM, et al. Treatment of soft tissue sarcomas by preoperative irradiation and conservative surgical resection. Int J Radiat Oncol 1988;14:693-9.
3. Brereton HD, Simon R, Pomeroy TC. Pretreatment serum lactatedehydrogenase predicting metastatic spread in Ewing's sarcoma. Ann Intern Med 1975;83:352-4.
4. Burdach S, Jürgens H, Peters C, et al. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 1993;11:1482-8.
5. Denny CT. Gene rearrangements in Ewing's sarcoma. Cancer Invest 1996;14:83-8.
6. Dockhorn-Dworniczak B, Pfleiderer C, Schäfer KL, et al. Molecular genetic detection of chimeric EWS-transcripts in blood and bone marrow samples of Ewing's tumor patients: Access to molecular staging. Joint Meeting EMSOS-AMSTS 1995 Florence, 8-9 May, 1995 (abstract). Florence: T.A.F. s.r.l., 28.
7. Dunst J, Burgers JMV, Hawliczek R, et al. Radiation therapy as local treatment in Ewing's sarcoma. Cancer 1991;67:2818-5.
8. Dunst J, Jürgens II, Sauer R, et al. Radiation therapy in Ewing's sarcoma: An update of the CESS 86 trial. Int J Radiat Oncol 1995;32:919-30.
9. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980;153:106-21.
10. Evans RG, Nesbit ME, Gehan EA, et al. Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: A report from the second intergroup study. J Clin Oncol 1991;9:1173-80.
11. Frassica FJ, Frassica DA, Pritchard DJ, et al. Ewing's sarcoma of the pelvis. Clinicopathological features and treatment. J Bone Joint Surg Am 1993;75:1457-65.
12. Göbel V. Jürgens H, Etspüler G, et al. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol 1987;113:187-91.
13. Hoffmann C, Jabar S, Ahrens S, et al. Prognosis in Ewing's sarcoma with initial pathological fracture. Klin Pädiatr 1995;207:151-7.
14. Hoffmann C, Jabar S, Jürgens H, et al. Pelvic Ewing's sarcoma: A retrospective analysis of 241 patients. Joint Meeting EMSOS-AMSTS Florence, 8-9 May, 1995. (abstract). Florence: T.A.F. s.r.l., 13.
15. Jeon IS, Davis JN, Braun BS, et al. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 1995;10:1229-34.
16. Jürgens H, Bier V, Harms D, et al. Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients. Cancer 1988;61:349-57.
17. Jürgens H, Exner U, Gadner H, et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of European Cooperative Trial. Cancer 1988;61:23-31.
18. Jürgens H, Hoffmann C, Braun-Munzinger G, et al. Histological response following preoperative chemoradiotherapy: The CESS experience. Joint Meeting EMSOS-AMSTS Florence, 8-9 May, 1995, (abstract). Florence: T.A.F. s.r.l., 63.
19. Jürgens H, Treuner J, Winkler K, et al. Ifosfamide in pediatric malignancies. Semin Oncol 1989;16:46-50.
20. Jürgens H, Winkler K, Gobel U. Bone tumours. In: Plowman PN, Pinkerton CR. Pediatric oncology - clinical practice and controversies. London: Chapman & Hall Medical, 1992:325-50.
21. Marcover RC, Rosen G. Radical en bloc excision of Ewing's sarcoma. Clin Orthop 1980;153:86-91.
22. Nag S, Olson T, Ruymann F, et al. High-dose-rate brachytherapy in childhood sarcomas: A local control strategy preserving bone growth and function. Med Ped Oncol 1995;25:463-9.
23. Nascimento AG, Unni KK, Pritchard DJ, et al. A clinicopathologic study of 20 cases of large-cell (atypical) Ewing's sarcoma of bone. Am J Surg Pathol 1980;4:29-36.
24. Ozaki T, Hillmann A, Hoffmann C, et al. Ewing's sarcoma of the femur. Prognosis in 69 patients treated by the CESS group. Acta Orthop Scand 1997;68:20-4.
25. Ozaki T, Hillmann A, Hoffmann C, et al. Significance of surgical margin in prognosis of patients with Ewing's sarcoma. Cancer 1996;78:892-900
26. Ozaki T, Hillmann A, Rübe C, et al. Surgical complications after preoperative irradiation of Ewing's sarcoma. J Cancer Res Clin Oncol 1996;123:57-62.
27. Ozaki T, Hillmann A, Rübe C, et al The impact of intraoperative brachytherapy on surgery of Ewing's sarcoma. J Cancer Res Clin Oncol 1996; 123:53-6.
28. Ozaki T, Lindner N, Hoffmann C, et al. Ewing's sarcoma of the ribs. A report from the cooperative Ewing's sarcoma study. Eur J Cancer 1995;31-A:2284-8.
29. Peat BG, Bell RS, Davis A, et al. Wound-healing complications after soft-tissue sarcoma surgery. Plast Reconstr Surg 1994; 93:980-7
30. Price CHG, Jeffree GM. Incidence of bone sarcomas in SW England, 1946-1974, in relation to age, sex, tumour site and histology. Br J Cancer 1977;36:511-22.
31. Rosen G, Caparross B, Mosende C, et al. Curability of Ewing's sarcoma and considerations for future therapeutic trials. Cancer 1978;41:888-99.
32. Rosen G, Caparros B, Nirenberg A, et al. Ewing's sarcoma: 10-year experience with adjuvant chemotherapy. Cancer 1981; 47:2204-13
33. Sailer SL, Harmon DC, Mankin HJ, et al. Ewing's sarcoma: Surgical resection as a prognostic factor. Int J Radiation Oncol 1988;15:43-52.
34. Salzer-Kuntschik M, Delling D, Beron G, et al. Morphological grades of regression m osteosarcoma after polychemotherapy: Study COSS 80. J Cancer Res Clin Oncol 1983;106:21-4.
35. Scully SP, Temple HT, O'Keefe RJ, et al. Role of surgical resection in pelvic Ewing's sarcoma. J Clin Oncol 1995;13:2336-41.
36. Sorensen PHB, Lessnick S, Lopez-Terrada D, et al. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nature Genet 1994;6:146-151.
37. Springfield DS, Pagliarulo C. Fracture of long bones previously treated for Ewing's sarcoma. J Bone Joint Surg Am 1985;67:477-81.
38. Terek RM, Brien EW, Marcove RC, et al. Treatment of femoral Ewing's sarcoma. Cancer 1996;78:70-8.
39. Turc-Carel C, Aurias A, Mugneret F, et al. Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases demonstrates remarkable consistency of t(11;22)(q24;q12). Can Genet Cytogenet 1988;32:229-38.
40. van Valen F, Winkelmann W, Burdach S, et al. Interferon γ and tumor necrosis factor α induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro. J Cancer Res Clin Oncol 1993;119:615-21.
41. Wilkins RM, Pritchard DJ, Burgert EO Jr, et al. Ewing's sarcoma of bone. Experience with 140 patients. Cancer 1986,58:2551-5.